Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034911.xml
Tierarztl Prax Ausg K Kleintiere Heimtiere 2025; 53(02): 96-102
DOI: 10.1055/a-2524-3760
DOI: 10.1055/a-2524-3760
Continuing Veterinary Education
Die feline infektiöse Peritonitis – ein aktueller Überblick
Feline infectious peritonitis – a current overview
Zusammenfassung
Coronaviren (CoVs) sind positiv einzelsträngige RNA-Viren, die verschiedene Tierarten sowie Menschen infizieren können. Besonders relevant für Katzen ist das feline Coronavirus (FCoV), das in Katzenpopulationen weltweit verbreitet ist. Eine Infektion mit FCoV verläuft in der Regel ohne Symptome. In Mehrkatzenhaushalten entwickeln jedoch etwa 5–12% der FCoV-infizierten Katzen aufgrund von Mutationen im Spike-Gen die feline infektiöse Peritonitis (FIP). FIP ist eine immunvermittelte Erkrankung, die bislang immer tödlich verlief. Die Mutationen führen zu einem Tropismus-Wechsel von Enterozyten zu Monozyten und Makrophagen. Der damit verbundene Wechsel in der Virulenz von FCoV führt zu der charakteristischen granulomatösen Vaskulitis und Perivaskulitis, die bei FIP beobachtet wird. In letzter Zeit gibt es zahlreiche neue Erkenntnisse zur FIP. So zeigen Studien, dass humanmedizinische antivirale Medikamente, wie das Nukleosidanalogon GS-441524, bei FIP wirksam sind und betroffenen Katzen eine Überlebenschance von bis zu 100% bieten. Zudem wurde eine neuartige FCoV-Variante, das FCoV-23, bei Katzen aus Zypern identifiziert. Dieses Virus entstand nach derzeitigem Kenntnisstand durch eine Rekombination zwischen FCoV und dem hochvirulenten pantropischen caninen Coronavirus; es kann direkt von Katze zu Katze übertragen werden und FIP auslösen. Darüber hinaus gibt es immer mehr Hinweise darauf, dass FIP häufig mit einer Myokarditis assoziiert ist. Dieser Artikel bietet einen Überblick über den aktuellen Wissensstand der FIP, unter Berücksichtigung der Pathologie, klinischer Symptome, wirksamer Therapiemöglichkeiten und Präventionsmaßnahmen.
Abstract
Coronaviruses (CoVs) are positive, single-stranded RNA viruses that can infect various animal species as well as humans. Particularly relevant for cats is the feline coronavirus (FCoV), which is widespread in cat populations worldwide. Infection with FCoV is usually asymptomatic. However, in multi-cat households, approximately 5–12% of FCoV-infected cats develop feline infectious peritonitis (FIP) due to mutations in the spike gene. FIP is an immune-mediated disease that previously was always fatal. These mutations result in a tropism shift from enterocytes to monocytes and macrophages. The associated change in the virulence of FCoV leads to the characteristic granulomatous vasculitis and perivasculitis observed in FIP. Recently, significant advancements have been made in understanding FIP. Studies show that antiviral drugs used in human medicine, such as the nucleoside analog GS-441524, are effective against FIP and can provide affected cats with a survival chance of up to 100%. Additionally, a novel FCoV variant, FCoV-23, has been identified in cats from Cyprus. According to newest research, this virus arose through a recombination between FCoV and the highly virulent pantropic canine coronavirus; it can be directly transmitted from cat to cat and lead to FIP. Furthermore, increasing evidence suggests that FIP is frequently associated with myocarditis. This article provides an overview of the current knowledge on FIP, including its pathology, clinical signs, effective treatment options, and preventive measures.
Schlüsselwörter
Katze - felines Coronavirus - FCoV - FIP - FCoV-23 - antivirale Therapie - GS-441524Publication History
Received: 22 March 2024
Accepted: 22 January 2025
Article published online:
15 April 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
Literatur
- 1 Payne S. Family coronaviridae. Viruses 2017; 158
- 2 Masters PS. The molecular biology of coronaviruses. Adv Virus Res 2006; 66: 193-292
- 3 Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 2016; 3: 237-261
- 4 Millet JK, Whittaker GR. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res 2015; 202: 120-134
- 5 Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997; 48: 1-100
- 6 Woo PCY, Lau SKP, Huang Y. et al. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood) 2009; 234: 1117-1127
- 7 Woo PCY, Lau SKP, Lam CSF. et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol 2012; 86: 3995-4008
- 8 Attipa C, Warr A, Epaminondas D. et al Emergence and spread of feline infectious peritonitis due to a highly pathogenic canine/feline recombinant coronavirus. bioRxiv 2023; [Preprint]
- 9 Binn L, Lazar E, Kp K. et al. Recovery and characterization of a coronavirus from military dogs with diarrhea. Proc Annu Meet U S Anim Health Assoc 1974; 78: 359-366
- 10 Doyle LP, Hutchings L. A transmissible gastroenteritis in pigs. J Am Vet Med Assoc 1946; 108: 257-259
- 11 Pensaert MB, de Bouck P. A new coronavirus-like particle associated with diarrhea in swine. Arch Virol 1978; 58: 243-247
- 12 Pedersen N, Boyle J, Floyd K. et al. An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res 1981; 42: 368-377
- 13 Addie DD, Jarrett O. A study of naturally occurring feline coronavirus infections in kittens. Vet Rec 1992; 130: 133-137
- 14 Addie DD, Jarrett O. Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet Rec 2001; 148: 649-653
- 15 Kipar A, Kremendahl J, Addie DD. et al. Fatal enteritis associated with coronavirus infection in cats. J Comp Pathol 1998; 119: 14
- 16 Haake C, Cook S, Pusterla N. et al. Coronavirus infections in companion animals: virology, epidemiology, clinical and pathologic features. Viruses 2020; 12
- 17 Clausen TM, Sandoval DR, Spliid CB. et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 2020; 183: 1043-1057
- 18 Cantuti-Castelvetri L, Ojha R, Pedro LD. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 2020; 370: 856-860
- 19 Garigliany M, Van Laere AS, Clercx C. et al. SARS-CoV-2 Natural transmission from human to cat, Belgium, March 2020. Emerg Infect Dis 2020; 26: 3069-3071
- 20 Liew AY, Carpenter A, Moore TA. et al. Clinical and epidemiologic features of SARS-CoV-2 in dogs and cats compiled through national surveillance in the United States. J Am Vet Med Assoc 2023; 261: 480-489
- 21 European Advisory Board on Cat Disease (ABCD). Feline infectious peritonitis (April 2022). Im Internet https://www.abcdcatsvets.org/wp-content/uploads/2022/12/ABCD-FCoV-FIP-Guidelines-April-2022.pdf Stand 07.02.2024
- 22 Barker EN, Tasker S. Advances in molecular diagnostics and treatment of feline infectious peritonitis. Adv Small Anim Care 2020; 1: 161-188
- 23 de Groot-Mijnes JDF, van Dun JM, van der Most RG. et al. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J Virol 2005; 79: 1036-1044
- 24 Fischer Y, Ritz S, Weber K. et al. Randomized, placebo controlled study of the effect of propentofylline on survival time and quality of life of cats with feline infectious peritonitis. J Vet Intern Med 2011; 25: 1270-1276
- 25 Ritz S, Egberink H, Hartmann K. Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis. J Vet Intern Med 2007; 21: 1193-1197
- 26 Pedersen NC, Eckstrand C, Liu H. et al. Levels of feline infectious peritonitis virus in blood, effusions, and various tissues and the role of lymphopenia in disease outcome following experimental infection. Vet Microbiol 2015; 175: 157-166
- 27 Chang HW, Egberink HF, Halpin R. et al. Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis 2012; 18: 1089-1095
- 28 Decaro N, Mari V, Lanave G. et al. Mutation analysis of the spike protein in Italian feline infectious peritonitis virus and feline enteric coronavirus sequences. Res Vet Sci 2021; 135: 15-19
- 29 Meli ML, Spiri AM, Zwicklbauer K. et al. Fecal feline coronavirus RNA shedding and spike gene mutations in cats with feline infectious peritonitis treated with GS-441524. Viruses 2022; 14: 1069
- 30 Tekes G, Hofmann-Lehmann R, Bank-Wolf B. et al. Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage. J Virol 2010; 84: 1326-1333
- 31 Tusell SM, Schittone SA, Holmes KV. Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range. J Virol 2007; 81: 1261-1273
- 32 Dye C, Temperton N, Siddell SG. Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines. J Gen Virol 2007; 88: 1753-1760
- 33 Warr A, Attipa C, Gunn-Moore D. et al. FCoV-23 causing FIP in a cat imported to the UK from Cyprus. Vet Rec 2023; 193: 414-415
- 34 Herrewegh AAPM, Smeenk I, Horzinek MC. et al. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 1998; 72: 4508-4514
- 35 Meli M, Kipar A, Müller C. et al. High viral loads despite absence of clinical and pathological findings in cats experimentally infected with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats. J Feline Med Surg 2004; 6: 69-81
- 36 Kipar A, Meli ML, Baptiste KE. et al. Sites of feline coronavirus persistence in healthy cats. J Gen Virol 2010; 91: 1698-1707
- 37 Vogel L, Van Der Lubben M, Te Lintelo EG. et al. Pathogenic characteristics of persistent feline enteric coronavirus infection in cats. Vet Res 2010; 41: 71
- 38 Pedersen NC, Allen CE, Lyons LA. Pathogenesis of feline enteric coronavirus infection. J Feline Med Surg 2008; 10: 529-541
- 39 Scott FW. Update on FIP. Proceedings of the 12th Kal Kan Symposium 1988; 1988: 43-47
- 40 André NM, Miller AD, Whittaker GR. Feline infectious peritonitis virus-associated rhinitis in a cat. J FMS Open Rep 2020; 6 2055116920930582
- 41 Barker EN, Tasker S, Gruffydd-Jones TJ. et al. Phylogenetic analysis of feline coronavirus strains in an epizootic outbreak of feline infectious peritonitis. J Vet Intern Med 2013; 27: 445-450
- 42 Licitra BN, Millet JK, Regan AD. et al. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg Infect Dis 2013; 19: 1066-1073
- 43 Drechsler Y, Alcaraz A, Bossong FJ. et al. Feline coronavirus in multicat environments. Vet Clin North Am Small Anim Pract 2011; 41: 1133-1169
- 44 Felten S, Klein-Richers U, Hofmann-Lehmann R. et al. Correlation of feline coronavirus shedding in feces with coronavirus antibody titer. Pathogens 2020; 9: 598
- 45 Klein-Richers U, Hartmann K, Hofmann-Lehmann R. et al. Prevalence of feline coronavirus shedding in german catteries and associated risk factors. Viruses 2020; 12: 1000
- 46 Pedersen NC. A review of feline infectious peritonitis virus infection: 1963-2008. J Feline Med Surg 2009; 11: 225-258
- 47 Addie DD, Toth S, Murray GD. et al. Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus. Am J Vet Res 1995; 56: 429-434
- 48 Riemer F, Kuehner KA, Ritz S. et al. Clinical and laboratory features of cats with feline infectious peritonitis-a retrospective study of 231 confirmed cases (2000-2010). J Feline Med Surg 2016; 18: 348-356
- 49 PH K, TH D. The epidemiology of feline infectious peritonitis in catteries. Feline Pract 1995; 23: 27-32
- 50 Rohrer C, Suter P, Lutz H. The diagnosis of feline infectious peritonitis (FIP): retrospective and prospective investigations. Kleintierpraxis 1993; 38: 379383
- 51 Kipar A, Baptiste K, Barth A. et al. Natural FCoV infection: cats with FIP exhibit significantly higher viral loads than healthy infected cats. J Feline Med Surg 2006; 8: 69-72
- 52 Fish EJ, Diniz PPVP, Juan YC. et al. Cross-sectional quantitative RT-PCR study of feline coronavirus viremia and replication in peripheral blood of healthy shelter cats in Southern California. J Feline Med Surg 2018; 20: 295-301
- 53 Sabshin SJ, Levy JK, Tupler T. et al. Enteropathogens identified in cats entering a Florida animal shelter with normal feces or diarrhea. J Am Vet Med Assoc 2012; 241: 331-337
- 54 Felten S, Klein-Richers U, Unterer S. et al. Role of feline coronavirus as contributor to diarrhea in cats from breeding catteries. Viruses 2022; 14: 858
- 55 Tsai HY, Chueh LL, Lin CN. et al. Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan. J Feline Med Surg 2011; 13: 74-80
- 56 Sparkes AH, Gruffydd-Jones TJ, Harbour DA. Feline infectious peritonitis: a review of clinicopathological changes in 65 cases, and a critical assessment of their diagnostic value. Vet Rec 1991; 129: 209-212
- 57 Spencer SE, Knowles T, Ramsey IK. et al. Pyrexia in cats: Retrospective analysis of signalment, clinical investigations, diagnosis and influence of prior treatment in 106 referred cases. J Feline Med Surg 2017; 19: 1123-1130
- 58 Kipar A, May H, Menger S. et al. Morphologic features and development of granulomatous vasculitis in feline infectious peritonitis. Vet Pathol 2005; 42: 321-330
- 60 Fischer Y, Wess G, Hartmann K. Pericardial effusion in a cat with feline infectious peritonitis. Schweiz Arch Tierheilkd 2012; 154: 27-31
- 79 Oliveira LB, Susta L, Rech RR. et al. Pathology in practice. Effusive FIP with fibrinous epicarditis in a cat. J Am Vet Med Assoc 2014; 245: 899-901
- 59 Baek SY, Jo JG, Song KH. et al. Recurrent pericardial effusion with feline infectious peritonitis in a cat. J Vet Clin 2017; 34: 437-440
- 80 Araujo GA, Matta EC, Lallo MA. et al. Epicarditis in a cat caused by feline infectious peritonitis virus: case report. Arq Bras Med Vet Zootec 2020; 72: 823-826
- 61 Kipar A, Koehler K, Bellmann S. et al. Feline infectious peritonitis presenting as a tumour in the abdominal cavity. Vet Rec 1999; 144: 118-122
- 62 Hugo TB, Heading KL. Prolonged survival of a cat diagnosed with feline infectious peritonitis by immunohistochemistry. Can Vet J 2015; 56: 53-58
- 63 Yin Y, Li T, Wang C. et al. A retrospective study of clinical and laboratory features and treatment on cats highly suspected of feline infectious peritonitis in Wuhan, China. Sci Rep 2021; 11: 5208
- 64 Healey EA, Andre NM, Miller AD. et al. Outbreak of feline infectious peritonitis (FIP) in shelter-housed cats: molecular analysis of the feline coronavirus S1/S2 cleavage site consistent with a ‘circulating virulent–avirulent theory’ of FIP pathogenesis. JFMS Open Rep 2022; 8 20551169221074226
- 65 Macdonald ES, Norris CR, Berghaus RB. et al. Clinicopathologic and radiographic features and etiologic agents in cats with histologically confirmed infectious pneumonia: 39 cases (1991-2000). J Am Vet Med Assoc 2003; 223: 1142-1150
- 66 Kline KL, Joseph RJ. Averill DRJr. Feline infectious peritonitis with neurologic involvement: clinical and pathological findings in 24 cats. J Am Anim Hosp Assoc 1994; 30: 111-118
- 67 Foley JE, Lapointe JM, Koblik P. et al. Diagnostic features of clinical neurologic feline infectious peritonitis. J Vet Intern Med 1998; 12: 415-423
- 68 Foley JE, Leutenegger C. A review of coronavirus infection in the central nervous system of cats and mice. J Vet Intern Med 2001; 15: 438-444
- 69 Negrin A, Lamb CR, Cappello R. et al. Results of magnetic resonance imaging in 14 cats with meningoencephalitis. J Feline Med Surg 2007; 9: 109-116
- 70 Negrin A, Cherubini GB, Lamb C. et al. Clinical signs, magnetic resonance imaging findings and outcome in 77 cats with vestibular disease: a retrospective study. J Feline Med Surg 2010; 12: 291-299
- 71 Kent M. The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS. J Feline Med Surg 2009; 11: 395-407
- 72 Ives EJ, Vanhaesebrouck AE, Cian F. Immunocytochemical demonstration of feline infectious peritonitis virus within cerebrospinal fluid macrophages. J Feline Med Surg 2013; 15: 1149-1153
- 73 Doenges SJ, Weber K, Dorsch R. et al. Detection of feline coronavirus in cerebrospinal fluid for diagnosis of feline infectious peritonitis in cats with and without neurological signs. J Feline Med Surg 2016; 18: 104-109
- 74 Crawford AH, Stoll AL, Sanchez-Masian D. et al. Clinicopathologic features and magnetic resonance imaging findings in 24 cats with histopathologically confirmed neurologic feline infectious peritonitis. J Vet Intern Med 2017; 31: 1477-1486
- 75 Mella SL, Cardy TJA, Volk HA. et al. Clinical reasoning in feline spinal disease: which combination of clinical information is useful?. J Feline Med Surg 2020; 22: 521-530
- 76 Norris JM, Bosward KL, White JD. et al. Clinicopathological findings associated with feline infectious peritonitis in Sydney, Australia: 42 cases (1990-2002). Aust Vet J 2005; 83: 666-673
- 77 Jinks MR, English RV, Gilger BC. Causes of endogenous uveitis in cats presented to referral clinics in North Carolina. Vet Ophthalmol 2016; 19: 30-37
- 78 Wegg ML, Jeanes EC, Pollard D. et al. A multicenter retrospective study into endogenous causes of uveitis in cats in the United Kingdom: ninety two cases. Vet Ophthalmol 2021; 24: 591-598
- 81 Yoshida T, Ichikawa N, Koike Y. et al. Two cats with dilated cardiomyopathy-like disease suspected of involvement in feline infectious peritonitis virus. J Vet Clin Med 2016; 25: 148-152
- 82 Ernandes MA, Cantoni AM, Armando F. et al. Feline coronavirus-associated myocarditis in a domestic longhair cat. JFMS Open Rep 2019; 5
- 83 Guarnieri C, Bertola L, Ferrari L. et al. Myocarditis in an FIP-diseased cat with FCoV M1058L mutation: clinical and pathological changes. Animals 2024; 14: 1673
- 84 Buchta K, Zuzzi-Krebitz AM, Bergmann M. et al. Nebenwirkungen während und nach Therapie der felinen infektiösen Peritonitis mit oralem GS-441524. Tieraerztl Praxis Ausg K 2024; 52: 59
- 85 Cannon MJ, Silkstone MA, Kipar AM. Cutaneous lesions associated with coronavirus-induced vasculitis in a cat with feline infectious peritonitis and concurrent feline immunodeficiency virus infection. J Feline Med Surg 2005; 7: 233-236
- 86 Declercq J, De Bosschere H, Schwarzkopf I. et al. Papular cutaneous lesions in a cat associated with feline infectious peritonitis. Vet Dermatol 2008; 19: 255-258
- 87 Bauer BS, Kerr ME, Sandmeyer LS. et al. Positive immunostaining for feline infectious peritonitis (FIP) in a Sphinx cat with cutaneous lesions and bilateral panuveitis. Vet Ophthalmol 2013; 16: 160-163
- 88 Redford T, Al-Dissi AN. Feline infectious peritonitis in a cat presented because of papular skin lesions. Can Vet J 2019; 60: 183-185
- 89 Trotman TK, Mauldin E, Hoffmann V. et al. Skin fragility syndrome in a cat with feline infectious peritonitis and hepatic lipidosis. Vet Dermatol 2007; 18: 365-369
- 90 Rota A, Paltrinieri S, Jussich S. et al. Priapism in a castrated cat associated with feline infectious peritonitis. J Feline Med Surg 2008; 10: 181-184
- 91 Addie D, Belák S, Boucraut-Baralon C. et al. Feline infectious peritonitis. ABCD guidelines on prevention and management. J Feline Med Surg 2009; 11: 594-604
- 92 Spada E, Carrera Nulla A, Perego R. et al. Evaluation of association between blood phenotypes A, B and AB and feline coronavirus infection in cats. Pathogens 2022; 11: 917
- 93 Tasker S, Addie DD, Egberink H. et al. Feline infectious peritonitis: european advisory board on cat diseases guidelines. Viruses 2023; 15: 1847
- 94 Leitlinie zur Impfung von Kleintieren, 5. Auflage (März 2023). Im Internet https://www.openagrar.de/servlets/MCRFileNodeServlet/openagrar_derivate_00051910/Impfleitlinie-Kleintiere-2023-03-01.pdf Stand 10.03.2024
- 95 Gerber JD, Ingersoll JD, Gast AM. et al. Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine. Vaccine 1990; 8: 536-542
- 96 Gerber JD. Overview of the development of a modified live temperature-sensitive FIP virus vaccine. Feline Pract 1995; 23: 62-66
- 97 Hoskins JD. The potential use of a modified live FIPV vaccine to prevent experimental FECV infection. Feline Pract 1995; 23: 89-90
- 98 Hoskins JD. Independent evaluation of a modified live feline infectious peritonitis virus vaccine under experimental conditions (Louisiana experience). Feline Pract 1995; 23: 72-73
- 99 McArdle F, Tennant B, Bennett M. et al. Independent evaluation of a modified live FIPV vaccine under experimental conditions (University of Liverpool experience). Feline Pract 1995; 23: 67-71
- 100 Scott FW, Corapi WV, Olsen CW. Independent evaluation of a modified live FIPV vaccine under experimental conditions (Cornell experience). Feline Pract 1995; 23: 74-76
- 101 Fehr D, Holznagel E, Bolla S. et al. Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: Safety and efficacy under field conditions. Vaccine 1997; 15: 1101-1109
- 102 Postorino RN. Vaccination against naturally occurring FIP in a single large cat shelter. Feline Pract 1995; 23: 81-82
- 103 Malin JJ, Bunse T, Spinner CD. et al. Antiviral drugs : Potent agents, promising therapies for COVID 19 and therapeutic limitations. Internist (Berl) 2022; 63: 118-128
- 104 Xie J, Wang Z. Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment. Acta Pharm Sin B 2021; 11: 1607-1616
- 105 Krentz D, Zenger K, Alberer M. et al. Curing cats with feline infectious peritonitis with an oral multi-component drug containing GS-441524. Viruses 2021; 13: 2228
- 106 Dickinson PJ, Bannasch M, Thomasy SM. et al. Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis. J Vet Intern Med 2020; 34: 1587-1593
- 107 Pedersen NC, Perron M, Bannasch M. et al. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg 2019; 21: 271-281
- 108 Krentz D, Zwicklbauer K, Felten S. et al. Clinical follow-up and postmortem findings in a cat that was cured of feline infectious peritonitis with an oral antiviral drug containing GS-441524. Viruses 2022; 14: 2040
- 109 Zwicklbauer K, Krentz D, Bergmann M. et al. Long-term follow-up of cats in complete remission after treatment of feline infectious peritonitis with oral GS-441524. J Feline Med Surg 2023; 25
- 110 Coggins S, Evans S. FIP treatment updates. Proceedings of the 7th ISCAID Symposium 2024; 2024: 56-59
- 111 VETIDATA. GS-441524: Legale Option zur FIP-Behandlung (November 2024). Im Internet https://vetidata.de/public/aktuelles/meldungen.php?params=113,74,65,74,139,131,74,67,74,50,123,117,137,50,75,131,74,67,74,50,65,71,71,50,75,141 Stand: 28.11.2024
- 112 Bohm M. Successful treatment of a South African cat with effusive feline infectious peritonitis with remdesivir. J S Afr Vet Assoc 2022; 93: 112-115
- 113 Green J, Syme H, Tayler S. A case series of 25 cats with effusive and non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524. 32. ECVIM-Kongress, Göteburg 2022;
- 114 Coggins SJ, Norris JM, Malik R. et al. Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524. J Vet Intern Med 2023; 37: 1772-1783
- 115 Green J, Syme H, Tayler S. Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524. J Vet Intern Med 2023; 37: 1784-1793
- 116 Cosaro E, Pires J, Castillo D. et al. Efficacy of oral remdesivir compared to GS-441524 for treatment of cats with naturally occurring effusive feline infectious peritonitis: a blinded, non-inferiority study. Viruses 2023; 15: 1680
- 117 Gordon CJ, Tchesnokov EP, Schinazi RF. et al. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template. J Biol Chem 2021; 297: 100770
- 118 Cook SE, Vogel H, Castillo D. et al. Investigation of monotherapy and combined anticoronaviral therapies against feline coronavirus serotype II in vitro. J Feline Med Surg 2022; 24: 943-953
- 119 Sheahan TP, Sims AC, Zhou S. et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med 2020; 12: 5883
- 120 Roy M, Jacque N, Novicoff W. et al. Unlicensed Molnupiravir is an effective rescue treatment following failure of unlicensed GS-441524-like therapy for cats with suspected feline infectious peritonitis. Pathogens 2022; 11: 1209
- 121 Sase O. Molnupiravir treatment of 18 cats with feline infectious peritonitis: A case series. J Vet Intern Med 2023; 37: 1876-1880